Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis

Arnold, Michael B.; Khanna, Dinesh; Denton, Christopher P.; van Laar, Jacob M.; Frech, Tracy M.; Anderson, Marina E.; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Riemekasten, Gabriela; Steen, Virginia; Mueller-Ladner, Ulf; Spotswood, Helen; Burke, Laura; Siegel, Jeffrey; Jahreis, Angelika; Furst, Daniel E.; Pope, Janet E.

dc.contributor.author	Fierlbeck, Gerhard
dc.date.accessioned	2020-01-20T14:06:51Z
dc.date.available	2020-01-20T14:06:51Z
dc.date.issued	2018
dc.identifier.issn	1462-0332
dc.identifier.uri	http://hdl.handle.net/10900/97197
dc.language.iso	en	en
dc.publisher	Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/rheumatology/kex396
dc.subject.ddc	610	de_DE
dc.title	Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_04605
utue.publikation.seiten	152-157	de_DE
utue.personen.roh	Arnold, Michael B.
utue.personen.roh	Khanna, Dinesh
utue.personen.roh	Denton, Christopher P.
utue.personen.roh	van Laar, Jacob M.
utue.personen.roh	Frech, Tracy M.
utue.personen.roh	Anderson, Marina E.
utue.personen.roh	Baron, Murray
utue.personen.roh	Chung, Lorinda
utue.personen.roh	Fierlbeck, Gerhard
utue.personen.roh	Lakshminarayanan, Santhanam
utue.personen.roh	Allanore, Yannick
utue.personen.roh	Riemekasten, Gabriela
utue.personen.roh	Steen, Virginia
utue.personen.roh	Mueller-Ladner, Ulf
utue.personen.roh	Spotswood, Helen
utue.personen.roh	Burke, Laura
utue.personen.roh	Siegel, Jeffrey
utue.personen.roh	Jahreis, Angelika
utue.personen.roh	Furst, Daniel E.
utue.personen.roh	Pope, Janet E.
dcterms.isPartOf.ZSTitelID	Rheumatology	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	57	de_DE
utue.fakultaet	04 Medizinische Fakultät